Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 32.75
+0.16 (0.49%)
Sep 2, 2026, 3:04 PM CST
SHE:300878 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 236.86 | 225.27 | 351.2 | 519.62 | 532.44 | 632.95 |
Revenue Growth | 40.34% | -35.86% | -32.41% | -2.41% | -15.88% | 1.64% |
Gross Profit Gross Profit Growth | 71 | 40.23 | 127.8 | 261.93 | 313.36 | 428.57 |
Operating Income Operating Income Growth | -79.9 | -125.14 | -161.53 | -19.9 | 54.24 | 83.62 |
Net Income Net Income Growth | -185.38 | -227.34 | -147.43 | -8.95 | 48.81 | 96.5 |
Earnings Per Share EPS Growth | -1.29 | -1.57 | -1.03 | -0.06 | 0.34 | 0.67 |
EPS Growth | - | - | - | - | -49.25% | -40.59% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 184.33 | 202.97 | 310.46 | 308.45 | 447.34 |
Pharmaceutical Wholesale and Retail Pharmaceutical Wholesale and Retail Growth | 36.35 | 144.04 | 204.09 | 220.96 | 183.84 |
Unallocated Other Operating Revenue/Costs Unallocated Other Operating Revenue/Costs Growth | - | 4.19 | 5.07 | 3.03 | 1.77 |
Other Operating Revenue/Costs Other Operating Revenue/Costs Growth | 4.6 | - | - | - | - |
Total Total Growth | 225.27 | 351.2 | 519.62 | 532.44 | 632.95 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 195.11 | 147.44 | 253.96 | 575.73 | 162.74 | 280.8 |
Total Debt Total Debt Growth | 234.37 | 164.94 | 292.57 | 435.24 | 319.1 | 82.34 |
Net Cash (Debt) Net Cash Growth | -39.26 | -17.5 | -38.61 | 140.48 | -156.36 | 198.46 |
Net Cash Growth | - | - | - | - | - | -65.81% |
Net Cash Per Share Net Cash Per Share Growth | -0.27 | -0.12 | -0.27 | 0.94 | -1.09 | 1.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -1.94 | 67.09 | -27.17 | 58.29 | 145.18 | -67.74 |
Capital Expenditures CapEx Growth | -54.4 | -67.17 | -126.92 | -139.29 | -173.39 | -171.1 |
Free Cash Flow Free Cash Flow Growth | -56.34 | -0.08 | -154.1 | -81 | -28.21 | -238.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 29.98% | 17.86% | 36.39% | 50.41% | 58.85% | 67.71% |
Operating Margin | -33.73% | -55.55% | -45.99% | -3.83% | 10.19% | 13.21% |
Pretax Margin | -72.90% | -92.54% | -45.07% | -1.28% | 11.86% | 15.80% |
Profit Margin | -78.26% | -100.92% | -41.98% | -1.72% | 9.17% | 15.25% |
FCF Margin | -23.79% | -0.04% | -43.88% | -15.59% | -5.30% | -37.73% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.140 | 0.250 | - | 0.300 |
Dividend Per Share Growth | -44.00% | - | - | -46.00% |
Dividend Yield | 0.94% | 1.01% | - | 1.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | 73.57 | 44.00 |
PS Ratio | 19.54 | 16.09 | 6.10 | 7.07 | 6.74 | 6.71 |